31st Scientific Meeting of the Malaysian Society of Pharmacology & Physiology (MSPP 2017)
Prima Nexus sponsored the 31st MSPP Scientific Meeting in Kubang Kerian, Kelantan, on 18 and 19 August 2017, themed Advancement in Research for Sustainable Health.
· Conference · Sponsored by Prima Nexus
About the meeting
MSPP 2017 was the 31st scientific meeting of the Malaysian Society of Pharmacology and Physiology. The society organised it together with the Health Campus of Universiti Sains Malaysia (USM), and the sessions took place at the School of Dental Sciences on that campus. Researchers and students from several universities took part, including USM and Universiti Teknologi MARA (UiTM).
What the programme covered
The meeting covered pharmacology, physiology, biochemistry, natural products, complementary medicine, clinical studies, pharmaceutical sciences, molecular biology, toxicology, pharmacogenetics and drug utilisation. Researchers presented their work as oral talks and as posters. The second announcement also listed a hands-on pre-conference workshop on natural product extraction methods for 17 August 2017.
The confirmed speakers were Professor Datuk Dr Asma Ismail, Dato' Professor Dr Jafri Malin Abdullah and Professor Dr Aida Hanum Ghulam Rasool of USM, Professor Soong Tuck Wah of the National University of Singapore, and Professor Dr Nafeeza Mohd Ismail of UiTM.
Prima Nexus's part
Prima Nexus sponsored the meeting. It provided the folders, pens and notepads given to delegates, and it supported the attendance of seven students from UiTM Sungai Buloh. The Prima Nexus logo appeared on the sponsors' panel of the meeting banner, where delegates posed for group photographs. For how Prima Nexus supports pharmacology and physiology research today, see animal studies and research.
More of our work with USM, UiTM.
About Prima Nexus
Prima Nexus Sdn Bhd is a Malaysian research coordination group founded in 2014. It runs hands-on training for researchers across Malaysia and eight scientific platforms under one roof: proteomics (including ELISA and Luminex multiplex immunoassays), genomics, flow cytometry, stem cell research, animal research, clinical trials, bioinformatics, and regulatory and grant support. More about Prima Nexus.
